Abstract
The molecular diagnosis of a genetic predisposition to breast cancer is now routinely available. BRCA1 and BRCA2 deleterious germline mutations confer very high risks of breast (80% by age 70 years) and ovarian cancer (15-40%). This justifies specific measures of screening, prevention and specific specialized care. The indications, methods and practical consequences of the diagnosis of a genetic predisposition are summarized, and specific care measures presented.
Translated title of the contribution | Genetic predisposition to breast and ovarian cancer: Molecular diagnosis and consequences |
---|---|
Original language | French |
Pages (from-to) | 213-218 |
Number of pages | 6 |
Journal | Oncologie |
Volume | 8 |
Issue number | 3 |
DOIs | |
Publication status | Published - 1 Jan 2006 |